Researchers believe a newly identified epigenomic fingerprint may be the key to identifying and possibly stopping the progression of many late-stage cancers. – TNS
An international research team led by Mayo Clinic oncologists has found a new way to identify and possibly stop the progression of many late-stage cancers.
The precision medicine study appears online in Oncogene and focuses on kidney cancer and its metastases.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
